tert-Butyl (2-((4-bromopyridin-2-yl)amino)-2-oxoethyl)carbamate

Catalog No. :
ACYQZK651
CAS No. :
2199007-37-7
Molecular Formula :
C12H16BrN3O3
Molecular Weight :
330.18

IUPAC Name:tert-butyl (2-((4-bromopyridin-2-yl)amino)-2-oxoethyl)carbamate

tert-Butyl (2-((4-bromopyridin-2-yl)amino)-2-oxoethyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$268.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-((4-bromopyridin-2-yl)amino)-2-oxoethyl)carbamate
IUPAC Nametert-butyl (2-((4-bromopyridin-2-yl)amino)-2-oxoethyl)carbamate
Molecular FormulaC12H16BrN3O3
Molecular Weight330.18
SMILESO=C(OC(C)(C)C)NCC(NC1=NC=CC(Br)=C1)=O
InChI KeyQAYQDBIQYRLEFH-UHFFFAOYSA-N
Synonymtert-butyl N-{[(4-bromopyridin-2-yl)carbamoyl]methyl}carba mate;Carbamic acid, N-[2-[(4-bromo-2-pyridinyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester
CAS No.2199007-37-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYQZK651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLTZU019 route compound structure diagram
    ACLTZU01984249-14-9 In Stock
  4. Then
  5. ACYQZK651 route product structure diagram
    ACYQZK6512199007-37-7
Inquiry

2. ACYQZK651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFZUD346 route compound structure diagram
    ACFZUD34614719-37-0 In Stock
  2. Plus
  3. ACLTZU019 route compound structure diagram
    ACLTZU01984249-14-9 In Stock
  4. Then
  5. ACYQZK651 route product structure diagram
    ACYQZK6512199007-37-7
Inquiry

Comments (0)